Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT01056718
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis (new or established) hypertension, defined by serial measurements \>/= 140/90
* Evidence of diastolic dysfunction on echocardiography measured by tissue Doppler
Exclusion Criteria:
* Severe bronchospastic disease/ reactive airway disease
* Inability to tolerate beta blocker therapy including: \>1st degree atrioventricular (AV) block, symptomatic hypotension, symptomatic bradycardia,
* Subjects with physical limitations that would prevent them from participating in an exercise treadmill test
* Age \<18 or \>90 years
* Those with life expectancy \<1 year
* Subjects with class III/IV New York Heart Association (NYHA) heart failure symptoms
* Chronic Kidney Disease 3 or greater (CrCl \<30 cc/min)
* Subjects with active ischemia or evidence of ischemia on initial stress echocardiography
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT01056718
Study Brief:
Protocol Section:
NCT01056718